• Value Research Rating market-capitalisation-info
    Not Applicable
  • Market Capitalisation market-capitalisation-info $6 Mln
  • Price to Earnings Ratio price-to-earning --
  • 12 Month Earnings monthly-earning $-51 Mln

Vapotherm Inc. (VAPO) Share Price

$1.03

As on 04-Mar-2024 15:59 EST

up-down-arrow $0.088.42%

  • Prev Close info

    $0.95

  • Day's Openinfo

    $0.95

  • Today's Highinfo

    $1.05

  • Today's Lowinfo

    $0.95

  • Today's Volumeinfo

    4,015

  • 52 Week rangeinfo

    $0.75 - 7.44

Please wait...

Vapotherm Inc. (VAPO) Stock Performance

YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Vapotherm (VAPO)
3.00 20.12 -59.45 -85.35 -82.36 -63.75 --
S&P BSE Sensex*
1.99 2.21 6.99 23.19 13.16 15.36 13.26
S&P Small-Cap 600#
-5.82 -5.34 -13.73 -6.30 5.30 2.98 5.53
As on 04-Mar-2024  |  *As on 05-Mar-2024  |  #As on 26-Oct-2023
2023
2022
2021
2020
2019
Vapotherm (VAPO)
-95.37 -86.96 -22.90 120.89 -39.05
S&P Small-Cap 600
13.89 -17.42 25.27 9.57 20.86
S&P BSE Sensex
18.74 4.44 21.99 15.75 14.38

Valuation Score

Stock
Peer Median
Please wait...

Growth & Efficiency

Stock
Peer Median
Please wait...

Solvency

Is there a threat to this company's solvency in the future?

Financial Manipulation

Can creative accounting be detected through the financial numbers?

Vapotherm Inc. (VAPO) Peer Comparison

search
search
search
search
    Please wait...

    Valuation Chart of Vapotherm Inc. (VAPO)

      Please wait...
        Please wait...

        Financials

        Please wait...
        Please wait...
        Please wait...

        Shareholding Pattern

        Other details of Vapotherm Inc. (VAPO)

        CEO, President & Director

        Mr. Joseph F. Army CPA

        Senior VP, CFO & Treasurer

        Mr. John Landry

        Headquarters

        Exeter, NH

        FAQs for Vapotherm Inc. (VAPO)

        The total asset value of Vapotherm Inc. (VAPO) stood at $ 97 Mln as on 30-Sep-23

        The share price of Vapotherm Inc. (VAPO) is $1.03 (NYSE) as of 04-Mar-2024 15:59 EST. Vapotherm Inc. (VAPO) has given a return of -82.36% in the last 3 years.

        Vapotherm Inc. (VAPO) has a market capitalisation of $ 6 Mln as on 28-Feb-2024. As per Value Research classification, it is a Small Cap company.

        The P/B ratio of Vapotherm Inc. (VAPO) is 7.11 times as on 28-Feb-2024, a 1.25% premium to its peers’ median range of 3.16 times.

        Since, TTM earnings of Vapotherm Inc. (VAPO) is negative, P/E ratio is not available.

        Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
        Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
        Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
        Step 4. Search for the Vapotherm Inc. (VAPO) and enter the required number of quantities and click on buy to purchase the shares of Vapotherm Inc. (VAPO).

        Vapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary high velocity therapy products used to treat patients of various ages suffering from respiratory distress in the United States and internationally. The company offers precision flow systems, such as HVT 2.0, Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox that deliver heated, humidified, and oxygenated air at a high velocity to treat patients through a small-bore nasal interface. It also provides companion products, including Vapotherm Transfer Unit, which allows patients to be transferred between care areas within the hospital or ambulate while on therapy; Q50 compressor, which provides compressed air necessary to run the precision flow systems; aerosol aeroneb adaptor to facilitate delivery of ultrasonic aerosolized medication; aerosol disposable patient circuit that is designed to streamline the provision of continuous and intermittent delivery of aerosol medication; and tracheostomy adaptors. In addition, Vapotherm, Inc. offers ProSoft cannula to provide gentle contact with the skin; and disposable products comprising single-use disposables and nasal interfaces, as well as Oxygen Assist Modules, which helps clinicians maintain oxygen levels within a target range. The company sells its products to hospitals. Vapotherm, Inc. was founded in 1993 and is headquartered in Exeter, New Hampshire. Address: 100 Domain Drive, Exeter, NH, United States, 03833

        The CEO & director of Mr. Joseph F. Army CPA. is Vapotherm Inc. (VAPO), and CFO & Sr. VP is Mr. John Landry.

        The promoters of Vapotherm Inc. (VAPO) have pledged 0% of the total equity as on Sep-23.

        Vapotherm Inc. (VAPO) Ratios
        Return on equity(%)
        --
        Return on capital employed(%)
        --
        Debt-to-equity ratio
        -2.2
        Dividend yield(%)
        0

        No, TTM profit after tax of Vapotherm Inc. (VAPO) was $-51 Mln.

        Edit peer-selector-edit
        Please wait...
        Please wait...

        Key Facts

        • Market cap market-cap-information $6.19 Mln
        • Revenue (TTM)revenue-information $67.60 Mln
        • Earnings (TTM) earning-information $-51.01 Mln
        • Cash date-information $14.42 Mln
        • Total Debt info $104.43 Mln
        • Insider's Holding 17.28%
        • Liquidity liquidity Moderate
        • 52 Week range week-range $0.75 - 7.44
        • Shares outstanding share-outstanding 6,138,330
        • 8 Years Aggregate:

          CFO: $-341.03 Mln

          EBITDA: $-288.07 Mln

          Net Profit: $-446.32 Mln

        About The Company

        • IPO Date 14-Nov-2018
        • CEO, President & Director Mr. Joseph F. Army CPA
        • Senior VP, CFO & Treasurer Mr. John Landry
        • Listing key-listing NYSE: VAPO
        • Country United States
        • Headquarters headquarters Exeter, NH
        • Website website https://www.vapotherm.com
        • Business

          Vapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary high velocity therapy products used to treat patients of various ages suffering from respiratory distress in the United States and...  internationally. The company offers precision flow systems, such as HVT 2.0, Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox that deliver heated, humidified, and oxygenated air at a high velocity to treat patients through a small-bore nasal interface. It also provides companion products, including Vapotherm Transfer Unit, which allows patients to be transferred between care areas within the hospital or ambulate while on therapy; Q50 compressor, which provides compressed air necessary to run the precision flow systems; aerosol aeroneb adaptor to facilitate delivery of ultrasonic aerosolized medication; aerosol disposable patient circuit that is designed to streamline the provision of continuous and intermittent delivery of aerosol medication; and tracheostomy adaptors. In addition, Vapotherm, Inc. offers ProSoft cannula to provide gentle contact with the skin; and disposable products comprising single-use disposables and nasal interfaces, as well as Oxygen Assist Modules, which helps clinicians maintain oxygen levels within a target range. The company sells its products to hospitals. Vapotherm, Inc. was founded in 1993 and is headquartered in Exeter, New Hampshire. Address: 100 Domain Drive, Exeter, NH, United States, 03833  Read more

        share-fund-plan-icon